Marco Colasanti Selected Research

Marco Colasanti Research Topics

Disease

12	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 11/2014
12	Neoplasms (Cancer) 05/2022 - 10/2008
4	Inflammation (Inflammations) 01/2016 - 06/2004
4	Glioma (Gliomas) 02/2009 - 06/2004
3	Liver Failure 06/2022 - 10/2020
3	Liver Diseases (Liver Disease) 05/2022 - 06/2015
3	Liver Neoplasms (Liver Cancer) 01/2022 - 12/2014
3	Hemorrhage 11/2021 - 10/2015
3	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 12/2002
3	Portal Hypertension 08/2021 - 06/2015
3	Fibrosis (Cirrhosis) 01/2021 - 12/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2018 - 06/2004
2	COVID-19 11/2021 - 06/2020
2	Thrombosis (Thrombus) 08/2021 - 01/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2021 - 06/2020
2	Klatskin Tumor 08/2021 - 01/2021
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 01/2021
2	Neurocognitive Disorders (Clerambault Syndrome) 05/2019 - 01/2016
2	Neuroblastoma 01/2016 - 10/2013
1	Pancreatic Fistula (Pancreatic Fistulas) 02/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Papilloma (Papillomatosis) 12/2019
1	Edema (Dropsy) 11/2017
1	Syncope (Fainting) 11/2017
1	Leiomyoma (Uterine Fibroids) 11/2017
1	Hypertension (High Blood Pressure) 05/2017
1	Esophageal and Gastric Varices (Esophageal Varices) 05/2017
1	Hepatitis 01/2017
1	Infections 10/2016
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Cavernous Hemangioma (Cavernous Angioma) 06/2015
1	Cognitive Dysfunction 05/2015
1	Cytomegalovirus Infections (Inclusion Disease) 01/2014
1	Acute Kidney Injury (Acute Renal Failure) 01/2014
1	Thrombotic Microangiopathies 01/2014
1	End Stage Liver Disease 01/2014
1	Long Term Adverse Effects 01/2014
1	Nervous System Diseases (Neurological Disorders) 02/2010
1	Rupture 09/2006
1	Necrosis 12/2005
1	Shock 12/2005

Drug/Important Bio-Agent (IBA)

3	Amyloid (Amyloid Fibrils)IBA 10/2021 - 12/2002
3	Yttrium-90IBA 02/2017 - 01/2017
2	Polyamine OxidaseIBA 09/2018 - 01/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2015 - 12/2005
2	IronIBA 02/2010 - 06/2004
2	Ceruloplasmin (Ferroxidase)IBA 02/2009 - 06/2004
1	Free RadicalsIBA 10/2021
1	1,2-cyclohexanediamine (dach)IBA 09/2018
1	SolutionsIBA 10/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2015
1	GoldIBA 12/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2014
1	Antiviral Agents (Antivirals)IBA 01/2014
1	Everolimus FDA Link 01/2014
1	PolyaminesIBA 10/2013
1	Familial apoceruloplasmin deficiencyIBA 02/2009
1	metal transporting protein 1 (ferroportin)IBA 02/2009
1	Levodopa (L Dopa)FDA LinkGeneric 10/2008
1	Arachidonic Acid (Vitamin F)IBA 01/2007
1	Matrix Metalloproteinases (MMPs)IBA 09/2006
1	NF-kappa B (NF-kB)IBA 09/2006
1	Interferon-gamma (Interferon, gamma)IBA 12/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2005
1	LipopolysaccharidesIBA 12/2005
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2005
1	Proteins (Proteins, Gene)FDA Link 06/2004
1	Interleukin-1beta (Interleukin 1 beta)IBA 06/2004

Therapy/Procedure

16	Liver Transplantation 05/2022 - 01/2014
9	Hepatectomy 06/2022 - 06/2015
8	Transplantation 11/2021 - 11/2014
3	Therapeutics 01/2022 - 01/2014
3	Microspheres (Microsphere) 02/2017 - 01/2017
3	Laparotomy 10/2015 - 08/2013
2	Ligation 06/2022 - 10/2020
2	Pancreaticoduodenectomy 02/2022 - 07/2013
1	Operative Surgical Procedures 08/2021
1	Pancreatectomy 12/2019
1	Highly Active Antiretroviral Therapy (HAART) 05/2019
1	Thrombectomy 04/2018
1	Hysterectomy 11/2017
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 05/2017
1	Length of Stay 03/2015
1	Boron Neutron Capture Therapy 10/2008